Table 5.
DEX | ||||||
---|---|---|---|---|---|---|
n = 19 | n = 27 | β | d | t-stat | P | |
SBP SDS, 24-h | 0.1 (1.1) | –0.2 (1) | 0.1 | 0.3 | 0.3 | .789 |
SBP SDS, daytime | 0 (1.1) | –0.3 (1.1) | 0.1 | 0.3 | 0.3 | .757 |
SBP SDS, nighttime | 0.4 (1) | 0 (0.9) | 0.3 | 0.4 | 0.9 | .356 |
DBP SDS (24-h) | –0.3 (0.7) | –0.1 (0.8) | –0.4 | –0.3 | –1.7 | .103 |
DBP SDS, daytime | –0.5 (0.8) | –0.5 (0.8) | –0.3 | 0.0 | –1.4 | .167 |
DBP SDS, nighttime | 0.3 (0.9) | 0.3 (0.7) | –0.1 | 0.0 | –0.4 | .692 |
MAP SDS, 24-h | 0.2 (0.7) | 0.1 (0.8) | –0.1 | 0.1 | –0.6 | .578 |
MAP SDS, daytime | –0.1 (0.8) | –0.2 (0.8) | –0.1 | 0.1 | –0.5 | .603 |
MAP SDS, nighttime | 0.6 (0.8) | 0.5 (0.7) | 0.0 | 0.1 | –0.1 | .959 |
β Coefficient values, Cohen d, t statistics, and P values for the main effect of DEX and the interaction between DEX and sex are presented. Controls exhibiting 24-hour, daytime or nighttime systolic and/or diastolic hypertension are excluded. No statistically significant between-group differences were observed.
Abbreviations: DBP, diastolic blood pressure; DEX, dexamethasone; M, mean; MAP, mean arterial pressure; SBP, systolic blood pressure; SDS, SD scores.